erlotinib has been researched along with 5-cyanouracil in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (5-cyanouracil) | Trials (5-cyanouracil) | Recent Studies (post-2010) (5-cyanouracil) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 9 | 0 | 5 |
| Protein | Taxonomy | erlotinib (IC50) | 5-cyanouracil (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.2 | |
| Dihydropyrimidine dehydrogenase [NADP(+)] | Homo sapiens (human) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Talele, TT | 1 |
1 other study(ies) available for erlotinib and 5-cyanouracil
| Article | Year |
|---|---|
Acetylene Group, Friend or Foe in Medicinal Chemistry.
Topics: Acetylene; Alkynes; Animals; Anti-Inflammatory Agents; Chemistry, Pharmaceutical; Click Chemistry; Half-Life; HIV Reverse Transcriptase; HIV-1; Humans; Macrophages; Mice; Protein Kinase Inhibitors; Rats; Reverse Transcriptase Inhibitors | 2020 |